Literature DB >> 23647294

New molecular insights in tobacco-induced lung cancer.

Giuseppe Tonini1, Loretta D'Onofrio, Emanuela Dell'Aquila, Aldo Pezzuto.   

Abstract

We know that cigarette smoking is a leading preventable cause of carcinogenesis in lung cancer. Cigarette smoke is a mixture of more than 5000 chemical compounds, among which more than 60 are recognized to have a specific carcinogenic potential. Carcinogens and their metabolites (i.e., N-nitrosamines and polycyclic aromatic hydrocarbons) can activate multiple pathways, contributing to lung cell transformation in different ways. Nicotine, originally thought only to be responsible for tobacco addiction, is also involved in tumor promotion and progression with antiapoptotic and indirect mitogenic properties. Lung nodules are frequent in smokers and can be transformed into malignant tumors depending on persistent smoking status. Even if detailed mechanisms underlying tobacco-induced cancerogenesis are not completely elucidated, this report collects the emergent body of knowledge in order to simplify the extremely complex framework that links smoking exposure to lung cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647294     DOI: 10.2217/fon.13.32

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  16 in total

1.  Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells.

Authors:  Alejandro Español; Yamila Sanchez; Agustina Salem; Jaqueline Obregon; Maria Elena Sales
Journal:  World J Clin Oncol       Date:  2022-06-24

Review 2.  Tobacco or healthy children: the two cannot co-exist.

Authors:  Philip Keith Pattemore
Journal:  Front Pediatr       Date:  2013-08-23       Impact factor: 3.418

3.  Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.

Authors:  Xing Chen; Fuyuan Wang; Liquan Lin; Hao Dong; Feifei Huang; Kanhar Ghulam Muhammad; Liying Chen; Olga Y Gorlova
Journal:  Int J Mol Sci       Date:  2017-10-25       Impact factor: 5.923

Review 4.  Clinical value of monoclonal antibodies and tyrosine kinase inhibitors in the treatment of head and neck squamous cell carcinoma.

Authors:  Wiktoria Blaszczak; Wojciech Barczak; Anna Wegner; Wojciech Golusinski; Wiktoria Maria Suchorska
Journal:  Med Oncol       Date:  2017-03-17       Impact factor: 3.064

5.  Association of DEAR1 Tagging Single Nucleotide Polymorphisms With Breast Cancer in a Sample of Colombian Population: A Case Control Study.

Authors:  Angela P Beltrán; Edgar Benitez; Martin Rondon; Yeimy V Ariza; Fabio A Aristizabal; Ignacio Briceño
Journal:  Breast Cancer (Auckl)       Date:  2020-04-20

6.  Baicalin Exerts Anti-Airway Inflammation and Anti-Remodelling Effects in Severe Stage Rat Model of Chronic Obstructive Pulmonary Disease.

Authors:  Genfa Wang; Nabijan Mohammadtursun; Yubao Lv; Hongying Zhang; Jing Sun; Jingcheng Dong
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-08       Impact factor: 2.629

7.  Sulforaphane Inhibits the Acquisition of Tobacco Smoke-Induced Lung Cancer Stem Cell-Like Properties via the IL-6/ΔNp63α/Notch Axis.

Authors:  Chunfeng Xie; Jianyun Zhu; Ye Jiang; Jiaqi Chen; Xueqi Wang; Shanshan Geng; Jieshu Wu; Caiyun Zhong; Xiaoting Li; Zili Meng
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

8.  Lysyl Oxidase Gene G473A Polymorphism and Cigarette Smoking in Association with a High Risk of Lung and Colorectal Cancers in a North Chinese Population.

Authors:  Guoli Wang; Yanqing Shen; Guang Cheng; Haimei Bo; Jia Lin; Maogen Zheng; Jianmin Li; Yinzhi Zhao; Wande Li
Journal:  Int J Environ Res Public Health       Date:  2016-06-28       Impact factor: 3.390

9.  Single Nucleotide Polymorphisms in HMGB1 Correlate with Lung Cancer Risk in the Northeast Chinese Han Population.

Authors:  Min Jiang; Xuelian Li; Xiaowei Quan; Xiaoying Li; Baosen Zhou
Journal:  Molecules       Date:  2018-04-04       Impact factor: 4.411

Review 10.  Blastomatoid pulmonary carcinosarcoma: A rare case report and review of the literature.

Authors:  Tadashi Sakane; Katsuhiro Okuda; Hideo Hattori; Takuya Watanabe; Risa Oda; Tsutomu Tatematsu; Keisuke Yokota; Hiroshi Haneda; Hiroshi Inagaki; Ryoichi Nakanishi
Journal:  Thorac Cancer       Date:  2018-08-14       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.